ABSTRACT<break><break>Background: Observational studies suggest that different classes of antihypertensive drugs may have different effects on the occurrence of intracranial aneurysm(IA) and subarachnoid hemorrhage(SAH). However, the reported effects in previous studies are inconsistent, and randomised data are absent. We performed a two-sample Mendelian randomization(MR) analysis to study the causal effects of genetically determined blood pressure(BP) and genetic proxies for antihypertensive drug classes on the risk of IA and SAH.<break><break>Methods: Genetic instruments and outcome data were obtained from independent genome-wide association studies(GWAS) or published data, which were exclusively restricted to european ancestry. Causal relationships were identified using inverse-variance weighted MR analyses and a series of statistical sensitivity analyses. The Finngen consortium was used for repeated analysis to verify results obtained from above GWAS.<break><break>Results: Two-sample MR analysis showed that genetically determined Systolic BP, Dystolic BP and Pulse Pressure were related to higher risk of IA and SAH. Based on indentified single nucleotide polymorphisms (SNPs) that influence the effect of calcium channel blockers (CCB, 43 SNPs), beta-blockers (BB, 30 SNPs), angiotensin-converting enzyme inhibitors (ACEI, 16 SNPs), angiotensin receptor blockers (ARB, 11 SNPs), and thiazides (5 SNPs), genetically determined effect of CCBs was associated with higher risk of IA (OR, 1.08 [95%CI, 1.04-1.12], P=1.2110-5) and SAH (OR, 1.07 [95%CI, 1.02-1.12], P=2.0510-3). No associations were found between other antihypertensive drugs and risk of IA or SAH. The effect of CCBs on SAH was confirmed in Finngen consortium samples(OR, 1.04 [95%CI, 1.00-1.08], P=0.042).<break><break>Conclusion: This MR analysis supports the protection effect of hypertension control on the occurrence of intracranial aneurysm and subarachnoid hemorrhage . However, genetic proxies for calcium channel blockers were associated with increased risk of intracranial aneurysm and subarachnoid hemorrhage. Further studies are required to confirm these findings and investigate the underlying mechanisms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.